Rod Carlo Columbres, DO
@rodcolumbres.bsky.social
Resident Physician 🩺☢️ | Aspiring Cancer Physician-Scientist | @ucla alum | Immigrant 🇵🇭| Work hard Dream big
Reposted by Rod Carlo Columbres, DO
🚨📃🔥 Our invited review on splicing dysregulation in urothelial carcinoma is now published in 𝘉𝘭𝘢𝘥𝘥𝘦𝘳 𝘊𝘢𝘯𝘤𝘦𝘳 Journal! @bladdercancer.bsky.social
A deep dive into the clinical, diagnostic, & therapeutic relevance of mRNA splicing alterations in #BladderCancer.
doi.org/10.1177/2352...
Check it out!
A deep dive into the clinical, diagnostic, & therapeutic relevance of mRNA splicing alterations in #BladderCancer.
doi.org/10.1177/2352...
Check it out!
October 30, 2025 at 10:31 PM
🚨📃🔥 Our invited review on splicing dysregulation in urothelial carcinoma is now published in 𝘉𝘭𝘢𝘥𝘥𝘦𝘳 𝘊𝘢𝘯𝘤𝘦𝘳 Journal! @bladdercancer.bsky.social
A deep dive into the clinical, diagnostic, & therapeutic relevance of mRNA splicing alterations in #BladderCancer.
doi.org/10.1177/2352...
Check it out!
A deep dive into the clinical, diagnostic, & therapeutic relevance of mRNA splicing alterations in #BladderCancer.
doi.org/10.1177/2352...
Check it out!
🚨📃🔥 Our invited review on splicing dysregulation in urothelial carcinoma is now published in 𝘉𝘭𝘢𝘥𝘥𝘦𝘳 𝘊𝘢𝘯𝘤𝘦𝘳 Journal! @bladdercancer.bsky.social
A deep dive into the clinical, diagnostic, & therapeutic relevance of mRNA splicing alterations in #BladderCancer.
doi.org/10.1177/2352...
Check it out!
A deep dive into the clinical, diagnostic, & therapeutic relevance of mRNA splicing alterations in #BladderCancer.
doi.org/10.1177/2352...
Check it out!
October 30, 2025 at 10:31 PM
🚨📃🔥 Our invited review on splicing dysregulation in urothelial carcinoma is now published in 𝘉𝘭𝘢𝘥𝘥𝘦𝘳 𝘊𝘢𝘯𝘤𝘦𝘳 Journal! @bladdercancer.bsky.social
A deep dive into the clinical, diagnostic, & therapeutic relevance of mRNA splicing alterations in #BladderCancer.
doi.org/10.1177/2352...
Check it out!
A deep dive into the clinical, diagnostic, & therapeutic relevance of mRNA splicing alterations in #BladderCancer.
doi.org/10.1177/2352...
Check it out!
Kudos to the brothers that came forward
Mom Convinced Daughter with Cancer to Reject Chemotherapy, Family Claims. She Died 7 Months Later
Kate Shemirani's sons told the BBC news program 'Panorama' that they believe she discouraged their sister from seeking chemotherapy for cancer, causing her death just seven months after her diagnosis.
people.com
June 26, 2025 at 1:53 AM
Kudos to the brothers that came forward
Reposted by Rod Carlo Columbres, DO
He needed air. The price was $539.
When OptumRx dropped coverage of his $66 inhaler, Cole couldn’t afford the new price.
5 days later, he died from a severe asthma attack—with no inhaler.
He paid with his life.
www.nbcnews.com/nightly-news... #MedSky #SciSky #PedsSky #PulmSky
When OptumRx dropped coverage of his $66 inhaler, Cole couldn’t afford the new price.
5 days later, he died from a severe asthma attack—with no inhaler.
He paid with his life.
www.nbcnews.com/nightly-news... #MedSky #SciSky #PedsSky #PulmSky
22-year-old dies after being unable to afford asthma inhaler
In our new series “The Cost of Denial,” NBC News’ Anne Thompson reports on the young man who went to refill his asthma inhaler only to find it unaffordable because it was no longer covered by his insu...
www.nbcnews.com
June 3, 2025 at 8:11 PM
He needed air. The price was $539.
When OptumRx dropped coverage of his $66 inhaler, Cole couldn’t afford the new price.
5 days later, he died from a severe asthma attack—with no inhaler.
He paid with his life.
www.nbcnews.com/nightly-news... #MedSky #SciSky #PedsSky #PulmSky
When OptumRx dropped coverage of his $66 inhaler, Cole couldn’t afford the new price.
5 days later, he died from a severe asthma attack—with no inhaler.
He paid with his life.
www.nbcnews.com/nightly-news... #MedSky #SciSky #PedsSky #PulmSky
🚨Proud to share our latest publication in @eururoloncol.bsky.social:
The burden of genitourinary cancers in Southeast Asia has risen significantly from 1990–2021. Findings highlight the urgent need for equitable access to cancer care in the region.
🔗 doi.org/10.1016/j.eu...
The burden of genitourinary cancers in Southeast Asia has risen significantly from 1990–2021. Findings highlight the urgent need for equitable access to cancer care in the region.
🔗 doi.org/10.1016/j.eu...
May 31, 2025 at 2:39 AM
🚨Proud to share our latest publication in @eururoloncol.bsky.social:
The burden of genitourinary cancers in Southeast Asia has risen significantly from 1990–2021. Findings highlight the urgent need for equitable access to cancer care in the region.
🔗 doi.org/10.1016/j.eu...
The burden of genitourinary cancers in Southeast Asia has risen significantly from 1990–2021. Findings highlight the urgent need for equitable access to cancer care in the region.
🔗 doi.org/10.1016/j.eu...
Yesterday I received one of the best emails ever. ☢️
This is for my family, friends, and mentors.
#Match2025 #radonc
This is for my family, friends, and mentors.
#Match2025 #radonc
March 18, 2025 at 12:41 PM
Yesterday I received one of the best emails ever. ☢️
This is for my family, friends, and mentors.
#Match2025 #radonc
This is for my family, friends, and mentors.
#Match2025 #radonc
Honored to contribute to this important work highlighting the current patterns of cancer incidence and mortality in southeast Asia led by the incredible Dr. E Chris Dee! Grateful to be part of such dedicated team!
🔗 www.thelancet.com/journals/lan...
🔗 www.thelancet.com/journals/lan...
March 1, 2025 at 2:32 PM
Honored to contribute to this important work highlighting the current patterns of cancer incidence and mortality in southeast Asia led by the incredible Dr. E Chris Dee! Grateful to be part of such dedicated team!
🔗 www.thelancet.com/journals/lan...
🔗 www.thelancet.com/journals/lan...
Wishing all of us #Match2025 applicants the best of luck for a successful match!
March 1, 2025 at 2:28 PM
Wishing all of us #Match2025 applicants the best of luck for a successful match!
Presenting our work on the burden of GU malignancies in Southeast Asia—come say hi at J4! @ascocancer.bsky.social #GU25
My last poster presentation as a medical student! 😁
My last poster presentation as a medical student! 😁
February 15, 2025 at 6:32 PM
Presenting our work on the burden of GU malignancies in Southeast Asia—come say hi at J4! @ascocancer.bsky.social #GU25
My last poster presentation as a medical student! 😁
My last poster presentation as a medical student! 😁